Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.71

€0.71

-4.830%
-0.036
-4.830%
€0.000

€0.000

 
29.09.22 / Tradegate WKN: A0B65S / Name: Paion / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€0.000
08.09.22
-21.53%
Best running prediction
€0.000
08.09.22
-21.53%
Your prediction

Paion AG Stock

Heavy losses for Paion AG today as the stock fell by -€0.036 (-4.830%).
With 1 Sell predictions and 0 Buy predictions the community sentiment towards the Paion AG stock is not clear.
For the coming years our community has positive and negative things to say abot the Paion AG stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Paion AG in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Paion AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Paion AG -4.830% -15.329% -23.568% -60.056% -41.474% -68.578% -74.319%
B.R.A.I.N. Biotechnology Research and Information Network AG -9.620% -16.606% -33.811% -53.707% -49.119% -59.756% -76.618%
MagForce AG 32.450% -49.091% -74.154% -98.930% -98.765% -99.232% -99.576%
Affimed N.V. -4.870% 1.118% -23.968% -58.710% -57.234% -28.976% -

Comments

Sell Paion AG
Show more

Prediction Buy
Perf. (%) -0.49%
Target price
Change
Ends at 02.01.20

Buy beendet
Show more

Buy Paion AG
Show more

News

DGAP-News: PAION AG reports financial results for the first half-year 2022: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-News: PAION AG reports financial results for the first half-year 2022
DGAP-News: PAION AG reports financial results for the first half-year 2022
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY
DGAP-News: ​​​​​​​PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-News: ​​​​​​​PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE
DGAP-News: ​​​​​​​PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE